Cargando…

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review

PURPOSE: Increased appreciation of the human epidermal growth factor receptor-2 (HER2/neu) signalling pathway has led to the development of targeted therapeutic agents used in conjunction with chemotherapy to improve outcomes for HER2 overexpressing (HER2+) breast cancer. For neoadjuvant therapy, re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Matthew G, Davey, Martin S, Richard, Vinitha, Wyns, William, Soliman, Osama, Miller, Nicola, Lowery, Aoife J, Kerin, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943461/ https://www.ncbi.nlm.nih.gov/pubmed/35340888 http://dx.doi.org/10.1177/11782234221086684

Ejemplares similares

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
por: Abbas Syed, Raza, et al.
Publicado: (2023)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020)

Comparing surgical outcomes of approaches to adrenalectomy — a systematic review and network meta-analysis of randomised clinical trials
por: Davey, Matthew G., et al.
Publicado: (2023)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Radiomic Detection of Malignancy within Thyroid Nodules Using Ultrasonography—A Systematic Review and Meta-Analysis
por: Cleere, Eoin F., et al.
Publicado: (2022)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer
por: Richard, Vinitha, et al.
Publicado: (2022)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
por: Tariq, Muhammad, et al.
Publicado: (2023)

Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
por: Bouz Mkabaah, Luis, et al.
Publicado: (2023)

MicroRNAs as Novel Biomarkers for Breast Cancer
por: Heneghan, H. M., et al.
Publicado: (2010)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2009)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer—A State-of-the-Art Review
por: Cronin, Michael, et al.
Publicado: (2023)

Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
por: Davey, Matthew G, et al.
Publicado: (2022)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment
por: Davies, Molly, et al.
Publicado: (2022)

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

General data protection regulations (2018) and clinical research: perspectives of patients and doctors in an Irish university teaching hospital
por: Davey, Matthew G., et al.
Publicado: (2021)

Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators
por: Richard, Vinitha, et al.
Publicado: (2023)

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review
por: Lunardi, Mattia, et al.
Publicado: (2022)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
por: McAnena, Peter, et al.
Publicado: (2022)

Effect of practice management softwares among physicians of developing countries with special reference to Indian scenario by Mixed Method Technique
por: Davey, Sanjeev, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4cffk885q196lpuj1b3ta2fm8l